Actor
portrayal
A 2023 Arcutis survey of 93 adults diagnosed with seborrheic dermatitis found that an average of 15 products (including over-the-counter, alternative, and prescription treatments) were reportedly used on a yearly basis.2
Effectively control seborrheic dermatitis and simplify treatment with a steroid-free foam.1
.
Once a day.
Anywhere.1
ZORYVE is for topical use only and not for ophthalmic, oral, or intravaginal use.1
A 2023 Arcutis survey of 93 adults diagnosed with seborrheic dermatitis found that an average of 15 products (including over-the-counter, alternative, and prescription treatments) were reportedly used on a yearly basis.2
Actor portrayal
ZORYVE (zor-EEV) is a steroid-free, once-daily foam designed to simplify seborrheic dermatitis control1
DRAMATIC 77% IGA SUCCESS AT WEEK 8, RESULTS AS EARLY AS WEEK 21-3*
SEE RESULTSTOLERABLE AND SAFE, FOR ANY LOCATION AND DURATION1,3
REVIEW SAFETY PROFILEONCE-DAILY, STEROID-FREE FOAM FOR ALL SKIN AND HAIR TYPES1
DISCOVER ONCE-DAILY FOAM*Trial 203 and STRATUM studies evaluated ZORYVE (n=458) vs vehicle (n=225) once daily for 8 weeks in patients with seborrheic dermatitis. The primary endpoint was IGA Success at Week 8, defined as a score of Clear (0) or Almost Clear (1) and a ≥2-grade improvement from baseline.
IGA = Investigator Global Assessment.
ZORYVE foam has the potential to become the standard of care for seborrheic dermatitis.”
—Arcutis Chief Medical Officer Patrick Burnett, MD, PhD, FAAD
Actor portrayal
ZORYVE Direct helps commercially insured patients get access and start ZORYVE treatment quickly and easily†
†Prescriptions will be delivered to the patient 1–2 days after processing.
Patient Access Support
Savings Program
Adherence Support